Showing results (31-40 of 443) with videos related to
Sort By:
Pageof 45
Annals of Hematology|March 28, 2015
Molecular monitoring of chronic myeloid leukemia: principles and interlaboratory standardizationNicholas C P Cross, Andreas Hochhaus, Martin C MüllerAnnals of Hematology|March 28, 2015
Causes of resistance and treatment choices of second- and third-line treatment in chronic myelogenous leukemia patientsAndreas Hochhaus, Thomas Ernst, Ekkehard Eigendorff, et al.Onkologie|January 31, 2012
Imatinib and beyond--targeting activated tyrosine kinases in myeloproliferative disordersAndreas Hochhaus, Andreas Reiter, Thomas Ernst, et al.Haematologica|January 16, 2014
Targeting the phosphoinositide 3-kinase pathway in hematologic malignanciesElias Jabbour, Oliver G Ottmann, Michael Deininger, et al.Cancer|February 2, 2010
Optimizing therapy for patients with chronic myelogenous leukemia in chronic phaseHagop M Kantarjian, Jorge Cortes, Paul La Rosée, et al.Hematology/Oncology Clinics of North America|November 8, 2011
BCR-ABL mutations in chronic myeloid leukemiaThomas Ernst, Paul La Rosée, Martin C Müller, et al.Blood|November 22, 2011
Low BCR-ABL expression levels in hematopoietic precursor cells enable persistence of chronic myeloid leukemia under imatinibAshu Kumari, Cornelia Brendel, Andreas Hochhaus, et al.Anti-Cancer Drugs|July 20, 2005
Liposomal encapsulated anti-cancer drugsRalf-Dieter Hofheinz, Senta Ulrike Gnad-Vogt, Ulrich Beyer, et al.Expert Review of Hematology|January 25, 2017
Safety issues and management of toxicities associated with new treatments for multiple myelomaAnnamaria Brioli, Lars-Olof Mügge, Andreas Hochhaus, et al.Medizinische Genetik : Mitteilungsblatt Des Berufsverbandes Medizinische Genetik E.V|June 5, 2024
Genetic alterations in myeloproliferative and myelodysplastic/myeloproliferative neoplasms - a practical guide to WHO-HAEM5Constanze Kühn, Katharina Hörst, Hans M Kvasnicka, et al.Pageof 45